2 results match your criteria: "Stroke Thrombectomy-Capable Cardiovascular Centre[Affiliation]"
MicroNET-covered stent (CGuard) routine use in acute carotid-related stroke - SAFEGUARD-STROKE Study: response to the Buffalo Group commentary.
Postepy Kardiol Interwencyjnej
September 2024
St. John Paul II Hospital in Krakow, Stroke Thrombectomy-Capable Cardiovascular Centre, Krakow, Poland.
A multi-center study of the MicroNET-covered stent in consecutive patients with acute carotid-related stroke: SAFEGUARD-STROKE.
Postepy Kardiol Interwencyjnej
June 2024
St. John Paul II Hospital in Krakow Stroke Thrombectomy-Capable Cardiovascular Centre, Krakow, Poland.
Introduction: Acute carotid-related stroke (CRS), with its large thrombo-embolic load and large volume of affected brain tissue, poses significant management challenges. First generation (single-layer) carotid stents fail to insulate the athero-thrombotic material; thus they are often non-optimized (increasing thrombosis risk), yet their use is associated with a significant (20-30%) risk of new cerebral embolism.
Aim: To evaluate, in a multi-center multi-specialty investigator-initiated study, outcomes of the MicroNET-covered (cell area ≈ 0.